SAM
PFE icon

Stembrook Asset Management’s Pfizer PFE Stock Holding History

Stembrook Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Hold
10,191
– – 0.21% 45
2026
Q1 		$286K Hold
10,191
– – 0.28% 35
2025
Q4 		$254K Buy
+10,191
New +$257K 0.24% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stembrook Asset Management's PFE Position: Q2 2026 in Review

Stembrook Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 10,191 shares worth $245K. The position accounts for 0.21% of the portfolio, ranked #45.

Stembrook Asset Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $286K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stembrook Asset Management held 10,191 shares of Pfizer worth $245K as of Q2 2026.
  • Stembrook Asset Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.21% of Stembrook Asset Management's portfolio in Q2 2026, its #45 holding.
  • Stembrook Asset Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Stembrook Asset Management's Pfizer position peaked at $286K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stembrook Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.